MAPT and Alzheimer disease: Support for the TGM2 cross-linking of Tau was garnered from experiments on brain tissue from PSP and AD patients, which revealed “significantly higher levels of ε–(γ-glutamyl) lysine cross-linking of PHF-tau” in disease-specific brain regions [138].